Entera Bio (ENTX) Accounts Payables (2017 - 2026)
Entera Bio (ENTX) reported Accounts Payables of $575,000 for Q2 2026, up 50.1% from $383,000 a year earlier and up 109.9% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Accounts Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Entera Bio posted Accounts Payables of $448,000, up 239.4% from FY2024.
- Accounts Payables has increased for three consecutive years, with a five-year compound annual growth rate of 22.3% (FY2020 to FY2025).
- By year, Accounts Payables came in at $132,000 in FY2024 (+59.0%), $83,000 in FY2023 (+388.2%), $17,000 in FY2022 (-89.8%) and $166,000 in FY2021 (+1.2%).
- The Q2 2026 figure ranks as the highest quarterly Accounts Payables since Q2 2021.
- Year over year, Accounts Payables has now increased in each of the last seven quarters, with growth averaging 120.1% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q2 2025 (growth of 455.1%); the low point was Q2 2022 (a decline of 92.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $274,000 (Q1 2026), $448,000 (Q4 2025) and $216,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Entera Bio | 132.59 Mn | 101.46 Mn | - | 575,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 575,000.00 |
| Mar 31, 2026 | 274,000.00 |
| Dec 31, 2025 | 448,000.00 |
| Sep 30, 2025 | 216,000.00 |
| Jun 30, 2025 | 383,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 69,000.00 |
| Mar 31, 2024 | 66,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 564,000.00 |
| Jun 30, 2023 | 240,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 17,000.00 |
| Sep 30, 2022 | 413,000.00 |
| Jun 30, 2022 | 109,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 166,000.00 |
| Jun 30, 2021 | 1.47 Mn |
API Access
Entera Bio Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();